Concepedia

Author

Michael Bourque

Radboud University Nijmegen

Also Known As

M Bourque, M. Bourque, M.R. Bourque, Michael Bourque, Michael R. Bourque

19

Publications

1.2K

Citations

8

H-Index

20

Concepts

All Affiliations

Radboud University NijmegenUnited States Military AcademyChildren's Hospital of PhiladelphiaGoethe University FrankfurtNational Cancer Institute
MB

About

Michael Bourque is an author at Radboud University Nijmegen specializing in medicine, patient safety, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

80

2

Health Sciences

1

1

18

3

General Academic Pediatrics

1

1

40

4

Hepatology

1

1

22

5

Microbiology

1

1

18

Michael Bourque

×

7

Publications

1.2K

Citations

7

H-Index

YearCitations

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz,

New England Journal of Medicine

2004

917

A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

Johan Maertens, Luís Madero, Anne F. Reilly,

The Pediatric Infectious Disease Journal

2010

138

SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS

Theoklis E. Zaoutis, Thomas Lehrnbecher, Andreas H. Groll,

The Pediatric Infectious Disease Journal

2009

40

Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non- <i>albicans Candida</i> Species: Review of the Caspofungin Database

Arnaldo Lopes Colombo, Angela Ngai, Michael Bourque,

Antimicrobial Agents and Chemotherapy

2010

40

Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study

B.E. de Pauw, Carole A. Sable, Thomas J. Walsh,

Transplant Infectious Disease

2006

32

Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and Cirrhosis

M. Rodríguez‐Torres, Albrecht Stoehr, Edward Gane,

Clinical Gastroenterology and Hepatology

2013

22

Synergism of Cefazolin-Gentamicin Against Enterococci

Michael Bourque, Richard Quintiliani, Richard C. Tilton

Antimicrobial Agents and Chemotherapy

1976

18

Page 1